Hepatitis C and depression

Depression and Anxiety

Volumn 7, Issue 4, 1998, Pages 188-193

  Yates, William R ^a,c   Gleason, Ondria ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c Department of Psychiatry ^*  (United States)

Author keywords

Hepatitis C; Interferon; Psychiatric intervention

Indexed keywords

ALCOHOL; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; INTERFERON; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CHRONIC HEPATITIS; DELIRIUM; DEPRESSION; DRUG INDUCED DISEASE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; VIRUS HEPATITIS;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; PATIENT CARE TEAM; RISK FACTORS; SICK ROLE;

EID: 0031821012     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:4<188::AID-DA7>3.0.CO;2-6     Document Type: Article

References (23)

1. Alter MJ (1997) Epidemiology of hepatitis C. Hepatology 26(3 Suppl 1):62S-65S.
2. Tobler LH, Busch MP (1997) History of posttransfusion hepatitis. Clin Chem 43:1487-1493.
3. Moyer LA, Alter MJ (1994) Hepatitis C virus in the hemodialysis setting: A review with recommendations for control. Semin Dialysis 7:124-127.
4. Puro V, Petrosillo N, Ippolito G (1995) Italian study group on occupational risk of HIV and other bloodborne infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 23:273-277.
5. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH (1996) Hepatitis C virus genotypes in the United States: Epidemiology, pathogenecity, and response to interferon therapy. Collaborative Study Group Ann Intern Med 125:634-639.
6. National Institutes of Health Consensus Development Conference Panel (1997) Management of hepatitis C. Hepatology 26(3 Suppl 1):2S-10S.
7. Serfaty L, Chazouilleres O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chretien Y, Poupon RE, Petit JC, Poupon R (1997) Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study. Hepatology 26:776-779.
8. Roudot-Thoraval F, Basie A, Pawlotsky JM, Dhumeaux D (1997) Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients. The Study Group for the Prevalence and Epidemiology of Hepatitis C Virus. Hepatology 26:485-490.
9. Noda K, Yoshihara H, Suzuki K, Yamada Y, Kasahara A, Hayashi N, Fusamoto H (1996) Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - its relationship to alcohol drinking and the age of transfusion. Alcohol Clin Exp Res 2:95A-100A.
10. Everhart JE, Stolar M, Hoofnagle JH (1997) Management of hepatitis C: A national survey of gastroenterologists and hepatologists. Hepatology 26(3 Suppl 1):78S-82S.
11. Cividini A, Pistorio A, Regazzetti A, Cerino A, Tinelli C, Mancuso A, Ribola M, Galli ML, Agnusdei A, Leone M, Silini E, Mondelli MU (1997) Hepatitis C virus infection among institutionalized psychiatric patients: A regression analysis of indicators of risk. J Hepatol 27:455-463.
12. Janssen HLA, Brouwer JT, van der Mast RC, Schalm SW (1994) Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 21:241-243.
13. Bourat L, Larrey D, Michel H (1995) Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of two cases. Gastroenterol Clin Biol 19:1063.
14. Carpinielio B, Orna MG, Baita A, Pariante CM (1998) Mania induced by withdrawal of treatment with interferon alpha. Arch Gen Psychiatry 55:88-89.
15. Otsubo T, Miyaoka H, Kamijima K, Onuki M, Ishii M, Mitamura K (1997) Depression during interferon therapy in chronic hepatitis C patients - a prospective study. Seishin Shinkeigaku Zasshi 99:101-127.
16. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K (1996) Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283-291.
17. Matsushita E, Unoura M, Kobayashi K (1994) Psychiatric complications of interferon therapy. Nippon Rinsho 52: 1910-1913.
18. Fattovich G, Giustina G, Favarato S, Ruol A (1996) A survey of adverse events in 11,241 patients with hepatitis treated with alfa interferon. J Hepatol 24:38-47.
19. Belle SH, Beringer KC, Detre KM (1996) Recent findings concerning liver transplantation in the United States. Clin Transplant 15-29.
20. Singh N, Gayowski T, Wagener MM, Marino IR (1997) Vulnerability to psychological distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant 11:406-411.
21. Levenson JL, Fallon HJ (1993) Fluoxetine treatment of depression caused by interferon-alpha. Am J Gastroenterol 88: 760-761.
22. Epstein SA (1994) Psychotropic medications in gastrointestinal and hepatic disease. In Silver PA (ed): Psychotropic Drug Use in the Medically Ill. Basel: Karger.
23. Trzepacz PT, DiMartini A, Tringali RD (1993) Psychopharmacologic issues in organ transplantation Part 2: Psychopharmacologic medications. Psychosomatics 34:290-298.